Table 3 Genes with the highest number of statistically significant probes (FDR < 0.01).

From: Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy

 

Gene symbol

CpG sites

PFDR range

FC range

Controls vs dialysis baseline

SKI

11

1.5 × 10–4 to 9.7 × 10–3

0.21–4.07

PRDM16

10

6.6 × 10–4 to 8.7 × 10–3

0.21–2.51

TRIM26

8

2.5 × 10–4 to 8.8 × 10–3

0.19–5.75

HDAC4

8

2.8 × 10–4 to 9.8 × 10–3

0.19–12.88

ZMIZ1

7

2.6 × 10–4 to 9.2 × 10–3

0.2–0.58

LOC146880

7

3.2 × 10–4 to 9.8 × 10–3

0.17–0.5

GFI1

7

1.1 × 10–4 to 8 × 10–3

0.08–0.24

HIVEP3

7

1.7 × 10–4 to 8.1 × 10–3

0.05–2.82

BAHCC1

7

7 × 10–4 to 8.7 × 10–3

0.32–0.46

Controls vs dialysis 12 months

MAD1L1

5

5.4 × 10–4 to 7.5 × 10–3

0.26–0.42

MYL9

4

2.9 × 10–3 to 6.1 × 10–3

0.25–0.37

LOC284837

4

4.6 × 10–4 to 3.5 × 10–3

0.33–0.45

SKI

3

1 × 10–3 to 8.9 × 10–3

0.28–3.8

PTPRCAP

3

6.7 × 10–3 to 7.2 × 10–3

1.86–2.82

PRDM16

3

2.6 × 10–3 to 5.9 × 10–3

0.32–0.47

MRFAP1

3

7.1 × 10–4 to 6.6 × 10–3

2.69–38.9

RPS11

3

3.3 × 10–3 to 6 × 10–3

3.63–17.78

FANCF

3

2.9 × 10–3 to 8.4 × 10–3

2.51–3.39

HDAC4

3

1.3 × 10–4 to 4.4 × 10–3

2.57–5.5

C17orf64

3

8.8 × 10–4 to 9.7 × 10–3

0.19–0.46

Controls vs KTx baseline

MAD1L1

34

4.6 × 10–7 to 9.2 × 10–3

0.11–22.91

HDAC4

29

6.4 × 10–6 to 8.9 × 10–3

0.07–14.45

RPTOR

28

1.2 × 10–6 to 5.1 × 10–3

0.07–9.77

TBCD

26

1.5 × 10–6 to 7.4 × 10–3

0.05–21.38

NCOR2

26

1.5 × 10–6 to 8.4 × 10–3

0.07–2.69

RASA3

22

4.8 × 10–7 to 9.1 × 10–3

0.05–9.12

KCNQ1

20

4.1 × 10–6 to 9.7 × 10–3

0.15–18.62

ANKRD11

19

4.4 × 10–7 to 8.9 × 10–3

0.09–7.41

BCL11B

18

4.7 × 10–7 to 2.7 × 10–3

0.3–35.48

Controls vs KTx 12 months

RASA3

11

2.9 × 10–4 to 9.5 × 10–3

0.09–5.62

MAD1L1

11

6.9 × 10–4 to 9.8 × 10–3

0.2–10.23

TBCD

9

4.9 × 10–4 to 9.2 × 10–3

0.13–4.79

RPTOR

9

7.3 × 10–4 to 9.2 × 10–3

0.15–3.89

DDR1

8

3.3 × 10–4 to 7.1 × 10–3

1.78–5.37

BANP

8

2.4 × 10–4 to 6.2 × 10–3

0.19–5.89

ARID3A

8

9 × 10–4 to 8.8 × 10–3

0.06–0.32

FOXK1

7

4.8 × 10–3 to 9.3 × 10–3

0.12–2.95

ITPKB

7

6.9 × 10–4 to 9.6 × 10–3

0.32–6.31

HDAC4

7

6.5 × 10–4 to 4.4 × 10–3

0.19–10.23

  1. FC range < 1 indicates less methylation in patients than in controls, while the opposite is true for FC range > 1.
  2. FDR false discovery rate, FC fold change, using healthy controls as a reference.